Dev

According to the latest US Alzheimer’s Association report, one in three seniors dies with Alzheimer’s or another dementia in the United States. The new report shows that while deaths from other major diseases, such as heart disease, HIV/AIDS and stroke,…

Promoting a shift to open science It is generally accepted that outputs from publicly-funded research should be publicly available not only to researchers, but also to potential users in education, business, charitable and public sectors, and to the general public. …

A systems biology & comparative genomics approach for studying human brain ageing and/or most common age-related diseases A new European group of academic laboratories and industrial scientists from SMEs will combine an integrative systems biology & comparative genomics approach for…

A new study supports the concept that prolonged and intensive environmental stimulation may have beneficial effects in delaying one of the key negative factors in Alzheimer’s disease. It is well known that staying mentally active throughout life lowers the risk…

Diseases include ALS and a form of dementia called IBMPFD Single mutations in one gene rarely cause different diseases. New research, published in the journal Neuron, gives insight into how single mutations in the VCP gene cause a range of…

Genome-wide imaging study identifies a new gene called BCHE, found to be associated with Alzheimer’s plaques The is the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid – florbetapir.  This imaging…

UK’s leading dementia research charity has launched a new research strategy dedicated to driving forward development of treatments. This strategic approach to research into dementia has four core components: Responsive and Targeted Funding New Drug Discovery Strategic Projects Partnerships More information…